Our Chief Operating Officer, Christopher Kennedy, recently presented at Pharma and Patient USA, a virtual event bringing together leaders in patient-centricity. Christopher shared our perspective on what it takes to deliver remarkable patient experiences to clinical trial participants.
mdgroup is proud to be a founding member of the Decentralised Clinical Trials and Research Alliance (DTRA).
In this in-depth guide, we look at all aspects of patient engagement across the entire clinical trial journey, and why it’s important in ensuring diversity amongst participants and looking after patients’ mental wellbeing.
Effective communication is essential for patient engagement and retention during a clinical trial – especially as more trials are moving to virtual or decentralised models.
There’s no doubt of the seismic impact COVID-19 has had on clinical trials. As a result of safety measures, the industry has had no choice but to start moving towards an approach which minimises or eliminates the need for travel and contact. As a result, more and more trials are being held virtually, and completely decentralised trials are increasingly more common.
In this comprehensive guide to improving patient retention in clinical trials, we explore the impact of a high level of patient focus and support on recruitment and retention rates. We’ll also offer our expert insight into key ways to prioritise patients at every stage of the clinical journey.
